Official Publications OSE Immunotherapeutics

Equities

Real-time Euronext Paris Other stock markets 08:59:22 2024-04-25 am EDT			5-day change	1st Jan Change
5.63 ^EUR	-0.18%		+12.00%	+30.84%

Apr. 17	OSE: licensing agreement with AbbVie enters into force	CF
Apr. 17	OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie	MT

Monthly statement on voting rights	Apr. 02	CO
Annual results	Mar. 26	CO
Annual results	Mar. 26	CO
Monthly statement on voting rights	Feb. 28	CO
Threshold crossings	Feb. 05	CO
Security operations	Feb. 05	CO
Monthly statement on voting rights	Jan. 30	CO
Threshold crossings	Jan. 08	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	23-10-30	CO
Monthly statement on voting rights	23-09-29	CO
1st-half-year results	23-09-26	CO
Half-year report	23-09-26	CO
Monthly statement on voting rights	23-08-30	CO
Monthly statement on voting rights	23-06-29	CO
Shareholders meeting voting results	23-06-21	CO
Monthly statement on voting rights	23-05-30	CO
Mixed general Shareholders meeting notice	23-05-14	CO
Monthly statement on voting rights	23-04-29	CO
Auditors Report	23-04-27	CO
Universal registration document	23-04-27	CO
Monthly statement on voting rights	23-03-30	CO
Monthly statement on voting rights	23-02-27	CO
Monthly statement on voting rights	23-01-30	CO